Biostax Corp. (BTAX)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
May 8, 2025, 9:30 AM EDT
Biostax Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
17.26K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Biostax News
- 2 months ago - Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration - GlobeNewsWire
- 1 year ago - Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception - GlobeNewsWire
- 1 year ago - Biostax Announces a Director Appointment of Influential Business Leader Craig Suro - GlobeNewsWire
- 1 year ago - Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors - GlobeNewsWire
- 1 year ago - Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment - GlobeNewsWire